Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Schizophrenia
Interventions: repetitive transcranial magnetic stimulation (active), repetitive transcranial magnetic stimulation (sham); Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 45 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Catonsville, Maryland

Conditions: Schizophrenia, Smoking Cessation, Tobacco Use
Interventions: Active deep transcranial magnetic stimulation (dTMS), Sham dTMS; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Fibromyalgia
Interventions: Traditional Acupuncture, Sham Treatment; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Schizophrenia Spectrum Disorders
Interventions: nVNS (non-invasive vagal nerve stimulation); Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Healthy, Neurologic Manifestations
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Pain, Intractable Pain
Interventions: Prodigy, Prodigy MRI or Proclaim Elite IPG; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 269 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 11
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 8 more

Conditions: Fatigue Syndrome, Chronic
Interventions: Thermal Pain Stimulation, Physical Effort Stimulation; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Traumatic Brain Injury
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 20 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Healthy
Interventions: Intranasal Oxytocin (OT) 24 IU, Intranasal Vasopressin (AVP), Intranasal Placebo, Intranasal Vasopressin (AVP) 40 IU, Lorazepam; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 707 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Healthy
Interventions: Cardiac MRI; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety Disorders
Interventions: 0.25 mg alprazolam, 1.0 mg alprazolam, placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 30 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Bipolar Disorder, Alcohol Drinking, Alcohol Use Disorder
Interventions: alcohol beverage, Placebo beverage; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 21 Years to 26 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Bipolar Disorder, Suicidal Ideation, Depression
Interventions: fMRI Scanning; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tinnitus
Interventions: Task-Based Functional Magnetic Resonance Imaging (fMRI); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 60 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoarthritis, Knee
Interventions: Acupuncture; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years to 70 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: ADHD
Interventions: Lisdexamfetamine; Drug
Lead sponsor: Jeffrey Newcorn; Other
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Bipolar Disorder
Interventions: Lithium; Drug
Lead sponsor: Indiana University; Other
Eligibility: 15 Years to 60 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Healthy
Interventions: Meditation Retreat; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Volunteers
Interventions: Insulin, Taste Task, Magnetic Resonance Imaging, Dextrose; Drug · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 30 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cocaine Use, Cocaine Dependence, Cocaine Use Disorder, Cocaine Use Disorder, Moderate, Cocaine Use Disorder, Severe
Interventions: Active H7-coil repetitive transcranial magnetic stimulation (rTMS), Sham H7-coil repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 22 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: AUD
Interventions: Nalmefene, Placebo; Drug · Other
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Aging
Interventions: Not listed
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 85 Years
Enrollment: 770 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Healthy Volunteers
Interventions: (2R,6R)-Hydroxynorketamine, Placebo; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Anorexia, Anorexia Nervosa
Interventions: Real-Time Functional Magnetic Resonance Imaging (RT-fMRI), Sham Procedure; Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

TMS for Inhibition Enhancement in Schizophrenia

Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

Developing Biomarkers for Fibromyalgia

Non-Invasive Vagus Nerve Stimulation as a Probe to Map Functional Connectivity in Schizophrenia Using Functional Magnetic Resonance Imaging

Study of Brain Changes Shaped by Experience

Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator

Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort

rTMS to Improve Cognitive Function in TBI

Biological Basis of Individual Variation in Social Cooperation

Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

Acute Alcohol Response In Bipolar Disorder: a fMRI Study

An fMRI Study on Temporal Discounting in Bipolar Disorder

Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus

Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Knee Pain

Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation

FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder

Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat

Insulin Modulation of fMRI Connectivity in Healthy Adults

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation

Arlington Aging Study

Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers

Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa